Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases
The Journal of Infection in Developing Countries · 2024
DOI: 10.3855/jidc.17870 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, 2024. Verfasst von Xin Miao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Chongqing University Three Gorges Hospital, Chongqing, China. Hauptthemen laut MEDLINE: Biomarkers, Hepatitis B, Chronic, Klotho Proteins, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing, National Natural Science Foundation of China.
Abstract (Originalsprache)
Introduction
Hepatitis B virus (HBV) infection is a global epidemic that can lead to several liver diseases, seriously affecting people's health. This study aimed to investigate the clinical potential of serum β-klotho (KLB) as a promising biomarker in HBV-related liver diseases. Methodology: This study enrolled 30 patients with chronic hepatitis B (CHB), 35 with HBV-related cirrhosis, 66 with HBV-related hepatocellular carcinoma (HCC), and 48 healthy individuals. ELISA measured the levels of serum KLB in the four groups. We then compared the differences in serum KLB levels among the groups and analyzed the relationship between serum KLB and routine clinical parameters.
Results
The concentrations of serum KLB levels were increased sequentially among the healthy subjects, the HBV-related CHB group, the HBV-related cirrhosis group, and the HBV-related HCC group (p < 0.05). Expression of KLB was positively correlated with alpha-fetoprotein (AFP), total bilirubin, direct bilirubin, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl-transferase, alkaline phosphatase, total bile acid, serum markers for liver fibrosis, ascites, cirrhosis, splenomegaly, and model for end-stage liver disease sodium, while negatively correlated with platelet count, albumin, and prothrombin activity (p < 0.05). In addition, serum KLB has better sensitivity in diagnosing HCC than AFP, and serum KLB combined with AFP has higher sensitivity and specificity than AFP alone in diagnosing HCC.
Conclusions
Serum KLB level is associated with the severity of HBV-related liver diseases and has important diagnostic value for HCC. Therefore, it could be a predictive biomarker for monitoring disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology, Chongqing University Three Gorges Hospital, Chongqing, China.
- Center for Medicine Research and Translation, Chengdu Fifth People's Hospital, Chengdu, Sichuan Province, China.
Förderung
- Natural Science Foundation of Chongqing
- National Natural Science Foundation of China
Zitieren
APA
Miao, X., Peng, C., Yan, F., Guo, X., Xia, L., Song, Q., An, X., & Wu, G. (2024). Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases. The Journal of Infection in Developing Countries. https://doi.org/10.3855/jidc.17870
Vancouver
Miao X, Peng C, Yan F, Guo X, Xia L, Song Q, et al. Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases. The Journal of Infection in Developing Countries. 2024. doi:10.3855/jidc.17870
BibTeX
@article{Miao2024,
author = {Miao, Xin and Peng, ChuYan and Yan, Fang and Guo, XiQing and Xia, LiNa and Song, Qiang and An, Xuan and Wu, GuiCheng},
title = {Serum β-klotho is a potential biomarker for the progression of hepatitis B virus-related liver diseases},
journal = {The Journal of Infection in Developing Countries},
year = {2024},
doi = {10.3855/jidc.17870}
}
EUVIMED